{
    "eid": "2-s2.0-85136928082",
    "title": "The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Teerada Susomboon",
        "Yotsaya Kunlamas",
        "Somratai Vadcharavivad",
        "Attapong Vongwiwatana"
    ],
    "citedby-count": 2,
    "ref-count": 48,
    "ref-list": [
        "Opportunities to optimize tacrolimus therapy in solid organ transplantation: Report of the European consensus conference",
        "Reduced exposure to calcineurin inhibitors in renal transplantation",
        "Failure of calcineurin inhibitor (tacrolimus) weaning randomized trial in long-term stable kidney transplant recipients",
        "Adverse outcomes of tacrolimus withdrawal in immune\u2013quiescent kidney transplant recipients",
        "Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives",
        "Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation",
        "Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients",
        "Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I",
        "Impact of POR and CYP3A5 polymorphisms on trough concentration to dose ratio of tacrolimus in the early post-operative period following kidney transplantation",
        "The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation",
        "Low systemic exposure to tacrolimus correlates with acute rejection",
        "Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection",
        "Higher tacrolimus trough levels on days 2\u20135 post-renal transplant are associated with reduced rates of acute rejection",
        "Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients",
        "The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation",
        "Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation",
        "Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein",
        "Kidney disease: Improving global outcomes transplant work group. KDIGO clinical practice guideline for the care of kidney transplant recipients",
        "Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: From retrospective to prospective",
        "ARCHITECT tacrolimus Ref1L77",
        "Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression",
        "A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype",
        "Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation",
        "Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation",
        "CYP3A5 polymorphisms in renal transplant recipients: Influence on tacrolimus treatment",
        "Frequencies of CYP3A5 genotypes and haplotypes in a Korean population",
        "Prevalence of CYP3A5 polymorphism in a Thai population",
        "CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations",
        "Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A",
        "Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite",
        "Role of CYP3A4 in human hepatic diltiazem N-demethylation:inhibition of CYP3A4 activity by oxidized diltiazem metabolites",
        "An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation",
        "Drug interactions with calcium channel blockers: Possible involvement of metabolite-intermediate complexation with CYP3A",
        "Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein",
        "Functional implications of genetic polymorphisms in the multidrug resistance gene",
        "Active drug transport of immuno-suppressants: New insights for pharmacokinetics and pharmacodynamics",
        "Pharmacokinetic interaction between tacrolimus and diltiazem: Dose\u2013response relationship in kidney and liver transplant recipients",
        "Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing",
        "Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients",
        "High tacrolimus clearance is a risk factor for acute rejection in the early phase after renal transplantation",
        "The tacrolimus metabolism rate influences renal function after kidney transplantation",
        "The TOMATO study (tacrolimus metabolization in kidney transplantation): Impact of the concentration\u2013dose ratio on death-censored graft survival",
        "Fast tac metabolizers at risk\u2014It is time for a C/D ratio calculation",
        "Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation",
        "Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease",
        "Cardiovascular complications after renal transplantation and their prevention",
        "Epidemiology of cardiovascular disease after renal transplantation",
        "Approach and management of hypertension after kidney transplantation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "Siriraj Hospital"
    ]
}